Global OTC Analgesic Gel Drug Market Growth (Status and Outlook) 2025-2031

The global OTC Analgesic Gel Drug market size is predicted to grow from US$ 5306 million in 2025 to US$ 7604 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

OTC analgesic gel drug refers to an over-the-counter (OTC) topical medication in gel form used to relieve pain. "Analgesic" means pain-relieving, and "gel" indicates the form in which the medication is applied to the skin. These gels typically contain active ingredients like menthol, camphor, or nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or diclofenac. They are commonly used for localized pain, such as muscle aches, joint pain, strains, or sprains.

United States market for OTC Analgesic Gel Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for OTC Analgesic Gel Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for OTC Analgesic Gel Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key OTC Analgesic Gel Drug players cover RB Health, Haleon, PERNATON, Kowa Company, Lead Chemical CO., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “OTC Analgesic Gel Drug Industry Forecast” looks at past sales and reviews total world OTC Analgesic Gel Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected OTC Analgesic Gel Drug sales for 2025 through 2031. With OTC Analgesic Gel Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Analgesic Gel Drug industry.

This Insight Report provides a comprehensive analysis of the global OTC Analgesic Gel Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on OTC Analgesic Gel Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Analgesic Gel Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Analgesic Gel Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Analgesic Gel Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of OTC Analgesic Gel Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:
Patches
Ointments

Segmentation by Application:
Online Sales
Offline Sales

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
RB Health
Haleon
PERNATON
Kowa Company
Lead Chemical CO., Ltd
MIKASA SEIYAKU CO.,LTD
Teikoku Pharma
China Biopharmaceutical Co., Ltd.
Jiangsu Innovent Biologics Co., Ltd.
Job Care Pharmaceutical Group Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.